How many other veterans and service members are not permitted to donate blood? Why?
What Happened to Mad Cow Disease?
If you were around in the '90s, you might remember the scare over mad cow disease, but it seems to have quieted down in the intervening years. What happened?...
[Note: I updated the question from "veterans" to "Veterans and service members" on June 6, 2015 - 71st anniversary of D Day - Operation Overlord]
[update May 18, 2018] As of 2017, worldwide 230 people, roughly 180 in the UK have been infected with vCJD and 4 people in the USA have been infected.
Mad Cow and VCJD are nervous system diseases which are based on diseased prions [not the car]. Diseased prions binds to proteins and converts them to prions.
https://www.youtube.com/watch?v=Pxojz6grwcU
Thanks to 1SG (Join to see) for alerting me that "there is progress in the development of methods to detect misfolded proteins in the bloodstream" I did research and found the following at an NIH site.
As this article informs us there has been progress in control groups testing of "developed blood tests to detect prion." The article states that there are plans to "validate their methods using larger samples sizes."
Hopefully this process will be successful to detect whether or not we have been infected by Creutzfeldt-Jakob Disease, Variant (vCJD); "Mad Cow Disease."
"Prion diseases are a group of rare, fatal brain diseases that affect animals and humans. They are caused by normally harmless proteins that become abnormal and form clumps in the brain. One form, called variant CJD (vCJD), is associated with eating meat from cattle infected with bovine spongiform encephalopathy, commonly known as “mad cow” disease.
People may have vCJD for years before symptoms—such as depression, hallucinations, moving difficulties, and dementia—appear. These “silent” carriers have small amounts of prions in their bloodstreams and can transmit the disease to others via blood transfusions. The only current method to diagnose vCJD is to perform a biopsy or a postmortem analysis of brain tissue. Thus, a noninvasive test to detect prions in blood is a medical priority.
Two research groups recently developed blood tests to detect prions. The results appeared in a pair of papers published on December 21, 2016, in Science Translational Medicine. One of the groups, led by Dr. Claudio Soto of the University of Texas Health Science Center at Houston, was funded in part by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), and National Center for Advancing Translational Sciences (NCATS).
Prions are scarce in the bloodstream and difficult to measure. Both teams developed methods to amplify the prions in blood samples using a technique called protein misfolding cyclic amplification (PMCA). PMCA relies on the characteristic nature of prions to cause certain healthy proteins to clump abnormally and convert into prions.
Soto’s group first combined healthy proteins with known concentrations of infectious vCJD prions. They intermittently agitated these mixtures with sound waves. The agitation helped break the prions into smaller chunks. This increased the number of prions that could then convert healthy proteins into prions. Using this method, the scientists were able to detect more than a billion-fold dilution of prions using an anti-prion antibody.
The scientists next tested whether the technique could be used to detect prions in blood samples from 14 people with vCJD and 153 controls. The controls included healthy people as well as people with different neurological or neurodegenerative disorders, including sporadic CJD, the most common form of CJD. The assay flagged all the vCJD samples correctly.
In the second paper, a French research group described a similar approach testing a blinded panel of blood samples. That team identified 18 vCJD patients in a group of 256 samples.
“Our findings, which need to be confirmed in further studies, suggest that our method of detection could be useful for the noninvasive diagnosis of this disease in pre-symptomatic individuals,” Soto says. Early diagnosis would allow potential therapies to be tested before substantial brain damage occurred. This technique would also allow blood contaminated with prions to be detected and removed from the blood supply.
Both teams are now working to validate their methods using larger samples sizes.
―by Anita Ramanathan
nih.gov/news-events/nih-research-matters/new-method-accurately-detects-prions-blood
~793507:LTC Bill Koski] CW5 (Join to see) MSG Brad Sand SGM Steve Wettstein SSG James J. Palmer IV aka "JP4" SP5 Mark Kuzinski SrA Christopher Wright PO1 William "Chip" Nagel PO1 John Miller SP5 Robert Ruck SPC (Join to see) PO3 Steven Sherrill SN Greg Wright Maj Marty Hogan SCPO Morris Ramsey TSgt Joe C. Cpl Joshua Caldwell SGT Michael Thorin SP5 Dave (Shotgun) Shockley SPC Margaret Higgins
FYI per Red Cross
In general donating blood is acceptable as long as you have been medically evaluated and treated, have no current (within the last 6 months) heart related symptoms such as chest pain and have no limitations or restrictions on your normal daily activities.
Wait at least 6 months following an episode of angina.
Wait at least 6 months following a heart attack.
Wait at least 6 months after bypass surgery or angioplasty.
Wait at least 6 months after a change in your heart condition that resulted in a change to your medications.
FYI COL Mikel J. Burroughs LTC Stephen C. LTC Thomas Tennant MAJ Ken LandgrenCapt Seid Waddell CW5 (Join to see) SGM David W. Carr LOM, DMSM MP SGT 1stSgt Eugene Harless SFC Joe S. Davis Jr., MSM, DSLSFC William FarrellSSG Leo Bell SSgt (Join to see) Sgt Joe LaBranche SrA Christopher Wright PO3 Steven Sherrill PO1 John Miller Kim Bolen RN CCM ACM SPC Margaret Higgins
I hope you are not commenting on "toxic blood" since blood-borne illness is still threat to those who need transfusions.
This is a military-service-member focused net and many of us who have served or still serve have a dark sense of humor based on what we have seen, heard, smelled, tasted and felt.
Some things haven't changed sir.
FYI COL Mikel J. Burroughs LTC Stephen C. LTC Orlando Illi LTC (Join to see) LTC Ivan Raiklin, Esq. Maj Bill Smith, Ph.D. Capt Seid Waddell Capt Jeff S. CPT Jack Durish MSgt Robert C Aldi SFC Stephen King MSgt Danny Hope SFC Joe S. Davis Jr., MSM, DSL SGT Gregory Lawritson Cpl Craig Marton SP5 Mark Kuzinski SGT (Join to see) Maj Marty Hogan
I am done. I am getting tested, I need to do it now or post mortem, I would rather do it now, and if cleared, I will give blood, if not, I hope that all who have been denied blood bank donations because of where you lived for 3 months or more, raise hell with your elected officials about this discriminatory cover up. Remember Agent Orange!
Thanks for making us aware that you also cannot donate blood because as a child your parent was stationed in Germany during the bovine spongiform encephalopathy (BSE) [Mad Cow] epidemic.
I am hopeful that in your lifetime there will e significant progress in the capability to detect the Creutzfeldt-Jakob Disease, Variant (vCJD) prions to determine if we are indeed infected by vCJD or confirm we are not.
Below is the background:
Thanks to SFC William Squires for alerting me that "there is progress in the development of methods to detect misfolded proteins in the bloodstream" I did research and found the following at an NIH site.
As this article informs us there has been progress in control groups testing of "developed blood tests to detect prion." The article states that there are plans to "validate their methods using larger samples sizes."
Hopefully this process will be successful to detect whether or not we have been infected by Creutzfeldt-Jakob Disease, Variant (vCJD); "Mad Cow Disease."
"Prion diseases are a group of rare, fatal brain diseases that affect animals and humans. They are caused by normally harmless proteins that become abnormal and form clumps in the brain. One form, called variant CJD (vCJD), is associated with eating meat from cattle infected with bovine spongiform encephalopathy, commonly known as “mad cow” disease.
People may have vCJD for years before symptoms—such as depression, hallucinations, moving difficulties, and dementia—appear. These “silent” carriers have small amounts of prions in their bloodstreams and can transmit the disease to others via blood transfusions. The only current method to diagnose vCJD is to perform a biopsy or a postmortem analysis of brain tissue. Thus, a noninvasive test to detect prions in blood is a medical priority.
Two research groups recently developed blood tests to detect prions. The results appeared in a pair of papers published on December 21, 2016, in Science Translational Medicine. One of the groups, led by Dr. Claudio Soto of the University of Texas Health Science Center at Houston, was funded in part by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), and National Center for Advancing Translational Sciences (NCATS).
Prions are scarce in the bloodstream and difficult to measure. Both teams developed methods to amplify the prions in blood samples using a technique called protein misfolding cyclic amplification (PMCA). PMCA relies on the characteristic nature of prions to cause certain healthy proteins to clump abnormally and convert into prions.
Soto’s group first combined healthy proteins with known concentrations of infectious vCJD prions. They intermittently agitated these mixtures with sound waves. The agitation helped break the prions into smaller chunks. This increased the number of prions that could then convert healthy proteins into prions. Using this method, the scientists were able to detect more than a billion-fold dilution of prions using an anti-prion antibody.
The scientists next tested whether the technique could be used to detect prions in blood samples from 14 people with vCJD and 153 controls. The controls included healthy people as well as people with different neurological or neurodegenerative disorders, including sporadic CJD, the most common form of CJD. The assay flagged all the vCJD samples correctly.
In the second paper, a French research group described a similar approach testing a blinded panel of blood samples. That team identified 18 vCJD patients in a group of 256 samples.
“Our findings, which need to be confirmed in further studies, suggest that our method of detection could be useful for the noninvasive diagnosis of this disease in pre-symptomatic individuals,” Soto says. Early diagnosis would allow potential therapies to be tested before substantial brain damage occurred. This technique would also allow blood contaminated with prions to be detected and removed from the blood supply.
Both teams are now working to validate their methods using larger samples sizes.
―by Anita Ramanathan
https://www.nih.gov/news-events/nih-research-matters/new-method-accurately-detects-prions-blood
FYI COL Mikel J. Burroughs LTC Stephen C. LTC (Join to see) Lt Col John (Jack) Christensen Lt Col Charlie Brown Maj Bill Smith, Ph.D. Maj William W. 'Bill' Price Maj Marty Hogan SCPO Morris Ramsey SGT Mark Halmrast Sgt Randy Wilber Sgt John H. SGT Gregory Lawritson CPL Dave Hoover SPC Margaret Higgins SSgt Brian Brakke 1stSgt Eugene Harless CPT Scott Sharon SSG William Jones
New method accurately detects prions in blood
A sensitive blood test accurately detected variant Creutzfeldt-Jakob disease, an incurable and fatal neurodegenerative disorder. The method could be used to diagnose prion diseases and prevent disease transmission.
Based on the American Red Cross from June 30, 2021
https://www.redcrossblood.org/donate-blood/how-to-donate/eligibility-requirements/eligibility-criteria-alphabetical/eligibility-reference-material.html
It seems that being stationed or being a dependent in Germany, Turkey and other duty stations in Europe [outside of the Great Britain, Ireland and France [for 5 years or more] has been lifted from the prohibition for donating blood lists.
At this time, the Food and Drug Administration’s (FDA) donor eligibility rules related to vCJD are as follows:
You are not eligible to donate if
From January 1, 1980, through December 31, 1996, you spent (visited or lived) a cumulative time of 3 months or more, in any country in the United Kingdom (UK),
Channel Islands England Falkland Islands Gibraltar Isle of Man Northern Ireland Scotland Wales
From January 1, 1980, to present, you had a blood transfusion in any of the countries listed below:
France Ireland Channel Islands England Falkland Islands Gibraltar Isle of Man Northern Ireland Scotland Wales
You spent (visited or lived) a cumulative time of 5 years or more from January 1, 1980, through December 31, 2001, in France or Ireland.
While military service members, veterans and their family members have the numbers, we didn't have the vast resources or political clout of those who lobbied hard for AIDS as a priority of research. Yes AIDS is a horrible way to die and so is vCJD. Those who die from vCJD ten to be grieved by their families and friends without coverage by "newscasters." CPL James Bennett Maj William W. 'Bill' Price Capt Seid Waddell Capt Tom Brown 1stSgt Eugene Harless CW5 John M. MSG Andrew White SSG James J. Palmer IV aka "JP4"SCPO Morris Ramsey SGT Michael Thorin SGT (Join to see) SGT Robert George SGT John " Mac " McConnell SP5 Mark Kuzinski SP5 Robert Ruck SPC Margaret Higgins Maj Marty Hogan SSgt Brian Brakke SFC Joe S. Davis Jr., MSM, DSL
Based on the American Red Cross from June 30, 2021
https://www.redcrossblood.org/donate-blood/how-to-donate/eligibility-requirements/eligibility-criteria-alphabetical/eligibility-reference-material.html
It seems that being stationed or being a dependent in Germany, Turkey and other duty stations in Europe [outside of the Great Britain, Ireland and France [for 5 years or more] has been lifted from the prohibition for donating blood lists.
At this time, the Food and Drug Administration’s (FDA) donor eligibility rules related to vCJD are as follows:
You are not eligible to donate if
From January 1, 1980, through December 31, 1996, you spent (visited or lived) a cumulative time of 3 months or more, in any country in the United Kingdom (UK),
Channel Islands England Falkland Islands Gibraltar Isle of Man Northern Ireland Scotland Wales
From January 1, 1980, to present, you had a blood transfusion in any of the countries listed below:
France Ireland Channel Islands England Falkland Islands Gibraltar Isle of Man Northern Ireland Scotland Wales
You spent (visited or lived) a cumulative time of 5 years or more from January 1, 1980, through December 31, 2001, in France or Ireland.
There is hope that one day we can be evaluated for vCJD without an autopsy :-)
Thanks to SFC William Squires for alerting me that "there is progress in the development of methods to detect misfolded proteins in the bloodstream" I did research and found the following at an NIH site.
As this article informs us there has been progress in control groups testing of "developed blood tests to detect prion." The article states that there are plans to "validate their methods using larger samples sizes."
Hopefully this process will be successful to detect whether or not we have been infected by Creutzfeldt-Jakob Disease, Variant (vCJD); "Mad Cow Disease."
"Prion diseases are a group of rare, fatal brain diseases that affect animals and humans. They are caused by normally harmless proteins that become abnormal and form clumps in the brain. One form, called variant CJD (vCJD), is associated with eating meat from cattle infected with bovine spongiform encephalopathy, commonly known as “mad cow” disease.
People may have vCJD for years before symptoms—such as depression, hallucinations, moving difficulties, and dementia—appear. These “silent” carriers have small amounts of prions in their bloodstreams and can transmit the disease to others via blood transfusions. The only current method to diagnose vCJD is to perform a biopsy or a postmortem analysis of brain tissue. Thus, a noninvasive test to detect prions in blood is a medical priority.
Two research groups recently developed blood tests to detect prions. The results appeared in a pair of papers published on December 21, 2016, in Science Translational Medicine. One of the groups, led by Dr. Claudio Soto of the University of Texas Health Science Center at Houston, was funded in part by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Neurological Disorders and Stroke (NINDS), and National Center for Advancing Translational Sciences (NCATS).
Prions are scarce in the bloodstream and difficult to measure. Both teams developed methods to amplify the prions in blood samples using a technique called protein misfolding cyclic amplification (PMCA). PMCA relies on the characteristic nature of prions to cause certain healthy proteins to clump abnormally and convert into prions.
Soto’s group first combined healthy proteins with known concentrations of infectious vCJD prions. They intermittently agitated these mixtures with sound waves. The agitation helped break the prions into smaller chunks. This increased the number of prions that could then convert healthy proteins into prions. Using this method, the scientists were able to detect more than a billion-fold dilution of prions using an anti-prion antibody.
The scientists next tested whether the technique could be used to detect prions in blood samples from 14 people with vCJD and 153 controls. The controls included healthy people as well as people with different neurological or neurodegenerative disorders, including sporadic CJD, the most common form of CJD. The assay flagged all the vCJD samples correctly.
In the second paper, a French research group described a similar approach testing a blinded panel of blood samples. That team identified 18 vCJD patients in a group of 256 samples.
“Our findings, which need to be confirmed in further studies, suggest that our method of detection could be useful for the noninvasive diagnosis of this disease in pre-symptomatic individuals,” Soto says. Early diagnosis would allow potential therapies to be tested before substantial brain damage occurred. This technique would also allow blood contaminated with prions to be detected and removed from the blood supply.
Both teams are now working to validate their methods using larger samples sizes.
―by Anita Ramanathan
https://www.nih.gov/news-events/nih-research-matters/new-method-accurately-detects-prions-blood
FYI LTC Jeff ShearerSGT Philip Roncari Lt Col Jim CoeCWO3 Dennis M.SGT (Join to see)PO3 Bob McCordSGT Jim Arnold Sgt Albert Castro PO3 Phyllis Maynard Maj Robert Thornton 1SG Carl McAndrews SPC Douglas Bolton Cynthia Croft PO1 H Gene Lawrence SGT Brent Scott CW5 John M. CMSgt (Join to see) PO2 Kevin Parker SGT James Murphy
New method accurately detects prions in blood
A sensitive blood test accurately detected variant Creutzfeldt-Jakob disease, an incurable and fatal neurodegenerative disorder. The method could be used to diagnose prion diseases and prevent disease transmission.
Based on the American Red Cross from June 30, 2021
https://www.redcrossblood.org/donate-blood/how-to-donate/eligibility-requirements/eligibility-criteria-alphabetical/eligibility-reference-material.html
It seems that being stationed or being a dependent in Germany, Turkey and other duty stations in Europe [outside of the Great Britain, Ireland and France [for 5 years or more] has been lifted from the prohibition for donating blood lists.
At this time, the Food and Drug Administration’s (FDA) donor eligibility rules related to vCJD are as follows:
You are not eligible to donate if
From January 1, 1980, through December 31, 1996, you spent (visited or lived) a cumulative time of 3 months or more, in any country in the United Kingdom (UK),
Channel Islands England Falkland Islands Gibraltar Isle of Man Northern Ireland Scotland Wales
From January 1, 1980, to present, you had a blood transfusion in any of the countries listed below:
France Ireland Channel Islands England Falkland Islands Gibraltar Isle of Man Northern Ireland Scotland Wales
You spent (visited or lived) a cumulative time of 5 years or more from January 1, 1980, through December 31, 2001, in France or Ireland.